Your session is about to expire
← Back to Search
Light Therapy
Broadband Light Treatment for Pigmentation Disorders
N/A
Recruiting
Led By Sherrif Ibrahim, MD
Research Sponsored by Sciton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy male or female, 18 years or older
Has visible signs of moderate to severe skin pigmentation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 weeks
Awards & highlights
Study Summary
This trial assesses the safety & effectiveness of a light-based skin treatment to improve wrinkles & acne.
Who is the study for?
Adults over 18 with moderate to severe skin pigmentation issues, Fitzpatrick skin types I-IV. Participants must limit sun exposure, use SPF 30+ sunscreen daily, avoid other skin treatments during the study, and not plan pregnancy. Excludes those with certain skin conditions or sensitivities, recent smokers, or those on light-sensitive medications.Check my eligibility
What is being tested?
The trial is testing Broadband Light treatment's safety and effectiveness for treating pigmented skin lesions. It involves a series of light-based treatments on the affected area while monitoring changes in the appearance of the skin.See study design
What are the potential side effects?
Potential side effects may include temporary redness or swelling at the treatment site, increased sensitivity to sunlight, blistering or bruising depending on individual reactions to light therapy. Long-term side effects are being evaluated as part of this study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years or older and in good health.
Select...
I have noticeable moderate to severe skin pigmentation.
Select...
I will not undergo any other skin treatments like lasers or injections during the study.
Select...
I am post-menopausal, surgically sterilized, or using reliable birth control and do not plan to become pregnant during the study.
Select...
I am willing to limit my sun exposure and use SPF 30+ sunscreen daily during the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pigmentation
Skin texture
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
Broadband light treatment using in-motion protocol
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Broadband Light
2022
N/A
~10
Find a Location
Who is running the clinical trial?
ScitonLead Sponsor
18 Previous Clinical Trials
1,296 Total Patients Enrolled
2 Trials studying Pigmentation
10 Patients Enrolled for Pigmentation
Sherrif Ibrahim, MDPrincipal InvestigatorRochester Dermatologic Surgery
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't had cosmetic treatments on the target area in the last 3 months.You have dark skin (Fitzpatrick skin type V-VI).I haven't taken retinoids or corticosteroids in the last 6 months.I have had radiation or chemotherapy for cancer.I have a history of skin color changes.You have a history of skin conditions like vitiligo, eczema, or psoriasis.I have no skin issues like cuts or large moles in the area to be treated.I have an infection, dermatitis, or rash where I would receive treatment.I am taking medication that makes my skin more sensitive to light.I have a connective tissue disease like lupus or scleroderma.You have had recurring herpes simplex or shingles in the area where treatment will be done, unless you are taking medicine to prevent it.You have smoked or used tobacco products in the past 6 months.I haven't had injections like Botox or fillers in the target area in the last week.I have had seizures triggered by lights.I have used gold therapy for conditions like rheumatoid arthritis or lupus.I have a history of immune system problems or am taking medication that weakens my immune system.I am willing to limit my sun exposure and use SPF 30+ sunscreen daily during the study.I am 18 years or older and in good health.Your skin type is between very light and light brown.I have noticeable moderate to severe skin pigmentation.I haven't used retinoid, corticosteroid, or hydroquinone on the target area in the last month.I will not undergo any other skin treatments like lasers or injections during the study.I am post-menopausal, surgically sterilized, or using reliable birth control and do not plan to become pregnant during the study.I have had cancer in the area being targeted for treatment.I have a blood clotting disorder or am on blood thinners.You have a history of abnormal or excessive scarring after injuries or surgeries.I have a serious health condition like uncontrolled high blood pressure or diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any more individuals being sought for participation in this research?
"As per the information accessible on clinicaltrials.gov, this investigation is presently recruiting participants. This study was initially posted in September 1st 2022 and underwent its latest update at February 27th 2023."
Answered by AI
How many individuals are actively participating in this experiment?
"Affirmative. Clinicaltrials.gov reports that this clinical study is presently searching for participants, having been first posted on September 1st 2022 and edited most recently on February 27th 2023. A total of 20 candidates are required at one medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger